Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated to proteinaceous toxin or fragment thereof
Patent
1997-05-05
1999-05-25
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated to proteinaceous toxin or fragment thereof
4241981, 4241931, 42419511, 514 12, 514 21, 435 697, 5303873, 53038822, 5303888, 5303917, A61K 39395, A61K 3843, C12P 2108, C07K 1628
Patent
active
059068205
ABSTRACT:
The invention features a method for treating a patient having inflammatory arthritis, the method includes administering to the patient a molecule which is capable of specifically binding to an epidermal growth factor receptor expressed on a cell of the patient which contributes to the inflammatory arthritis of the patient, the molecule being capable of decreasing the viability of the cell.
REFERENCES:
patent: 4468382 (1984-08-01), Bacha et al.
patent: 4946778 (1990-08-01), Ladner et al.
Schwartz et al., pp. 1065-1067, Fundamentals Immunology by Bill Paul 3rd Edition, 1993.
Schwartz et al., pp. 840-849, Fundamental Immunology by Bill Paul 2nd Edition, 1989.
Yocum et al., Abstract D98, pS150, 54 Annual Meeting American College of Rhemeutology, Seattle, WA., 1990.
Johnson et al., U.S. Department of Health and Human Services, U.S. Serial No. 401,412.
Huse et al., Science 246:1275-1281, 1989.
Case et al., Proc. Natl. Acad. Sci. USA 86:287-291, 1989.
Zvaifler et al., The American Journal of Medicine 85:12-17, 1988.
Defeo-Jones et al., Molecular and Cellular Biology, 8:2999-3007, 1988.
Stunkel et al., Immunology 64:683-689, 1988.
Williams et al., Nucleic Acids Research 16:10453-10467, 1988.
Calderwood et al., Proc. Natl. Acad. Sci. USA 84:4364-4368, 1987.
Hwang et al., Cell 48:129-136, 1987.
Colombatti et al., The Journal of Biological Chemistry, 261:3030-3035, 1986.
Holoshitz et al., The Lancet 305-309, 1986.
Hertel et al., The Journal of Biological Chemistry 260:12547-12553, 1985.
Moya et al., The Journal of Cell Biology 101:548-559, 1985.
Hoch et al., Proc. Natl. Acad. Sci. USA 82:1692-1696, 1985.
Amann et al., Gene 40:183-190, 1985.
Gray et al., Proc. Natl. Acad. Sci. USA 81:2645-2649, 1984.
Beguinot et al., Proc. Natl. Acad. Sci. USA 81:2384-2388, 1984.
Deleers et al., FEBS 160:82-86, 1983.
Maassen et al., Euro. J. Biochem. 134:327-330, 1983.
Beck et al., Gene 19:327-336, 1982.
Moynihan et al., Infection and Immunity, 32:575-582, 1981.
Uchiyama et al., The Journal of Immunology 126:1393-1397, 1981.
Trentham et al., The Journal of Experimental Medicine 146:857-868, 1977.
Pappenheimer, Ann. Rev. Biochem. 46:69-94, 1977.
Uchida et al., The Journal of Biological Chemistry 248:3838-3844, 1973.
Chaudhary, Vijay K. et al., Proc. Natl. Acad. Sci., USA, vol. 84, pp. 4538-4542 (Jul. 1987).
Shaw et al., "Cytotoxic Properties of DAB.sub.486 EGF and DAB.sub.389 EGF, Epidermal Growth Factor (EGF) Receptor-targeted Fusion Toxins", The Journal of Biological Chemistry, 266(31):21118-21124, (1991).
Williams et al., "Structure/Function Analysis of Interleukin-2-Toxin (DAB.sub.486 -IL-2)", The Journal of Biological Chemistry, 265(2):11885-11889, (1990).
Bansal Geetha P.
Hutzell Paula K.
Seragen, Inc.
LandOfFree
Epidermal growth factor receptor targeted molecules for treatmen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epidermal growth factor receptor targeted molecules for treatmen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epidermal growth factor receptor targeted molecules for treatmen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-400330